There is widespread hope Moderna’s vaccine will play an important role in combating the pandemic. With the stakes incredibly high, the mystery around a key technological component of Moderna’s coronavirus vaccine has only become deeper. As a result, any mRNA vaccine or therapeutic consists of two components, the actual sequence mRNA and the delivery mechanism. The preprint described Moderna’s coronavirus vaccine candidate as using delivery technology that appears to be covered in the Arbutus patent that was upheld last week. Taxpayers also might have an interest in knowing the ownership of the delivery technologies used by an mRNA vaccine backed by nearly $1 billion of federal government funds.

Source: Forbes July 29, 2020 11:48 UTC